News for BeiGene Ltd (spons. ADRs)

Seeking Alpha 484d

Arcus shares extend gains amid mixed reactions on Gilead stake purchase

TipRanks 489d

Analysts Are Bullish on These Healthcare Stocks: BeiGene (BGNE), Travere Therapeutics (TVTX)

TipRanks 502d

BeiGene’s Hold Rating: Balancing BGB-16673’s Promise with Market Realities

TipRanks 503d

Wall Street Analysts Are Bullish on Top Healthcare Picks

TipRanks 503d

Leerink Partners Sticks to Its Buy Rating for BeiGene (BGNE)

Benzinga 504d

As China's Population Declines In 2023, Will Aging Demographics Boost Healthcare Stocks?

TipRanks 504d

BeiGene Holds Steady: A Balanced View Amidst Growth and Market Uncertainty

TipRanks 530d

BeiGene’s Promising Pipeline and Buy Rating Endorsed by Analyst Jill Wu

TipRanks 531d

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), BeiGene (BGNE) and Lucid Diagnostics (LUCD)

TipRanks 531d

Analysts Offer Insights on Healthcare Companies: Lucid Diagnostics (LUCD), Edwards Lifesciences (EW) and BeiGene (BGNE)

TipRanks 532d

Buy Rating Affirmed for BeiGene Amid Promising CLL Treatment Advances with Brukinsa

TipRanks 548d

Analysts Offer Insights on Healthcare Companies: Merus (MRUS), Structure Therapeutics, Inc. Sponsored ADR (GPCR) and BeiGene (BGNE)

TipRanks 552d

Analysts Offer Insights on Healthcare Companies: BeiGene (BGNE), Karuna Therapeutics (KRTX) and Theseus Pharmaceuticals (THRX)

TipRanks 561d

Buy Recommendation for BeiGene: Strong Sales, Potential FDA Approval, and Improved Operating Efficiencies

TipRanks 561d

BeiGene’s Strong Performance in 3Q23 with Brukinsa Sales Surpassing Expectations Supports Analyst’s Buy Rating

Markets Insider Automation 565d

BeiGene is about to announce earnings — here's what Wall Street expects

TipRanks 565d

BeiGene’s Continued Growth and Market Dominance Earns a Buy Rating: An Analysis of Q3 2023 Performance

InvestorPlace 565d

7 Biotech Stocks to Buy for Big-Time Gains

TipRanks 565d

BeiGene’s Robust Growth and Financial Health Triggers Buy Rating: A Deep Dive into the Driving Factors

Benzinga 569d

Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga 569d

Ryanair Holdings, Prime Medicine And Other Big Stocks Moving Higher In Monday's Pre-Market Session

Benzinga 576d

Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga 576d

Western Digital, JinkoSolar, Lumentum Holdings And Other Big Stocks Moving Higher On Monday

Benzinga 576d

Why Biophytis Shares Are Trading Higher By Over 12%: Here Are 20 Stocks Moving Premarket

InvestorPlace 582d

Quant Ratings Updated on 62 Stocks

TipRanks 590d

Analysts’ Top Healthcare Picks: BeiGene (BGNE), Moderna (MRNA)

TipRanks 590d

Analysts Offer Insights on Healthcare Companies: Illumina (ILMN), UnitedHealth (UNH) and BeiGene (BGNE)

Benzinga 615d

Citigroup Maintains Buy Rating for BeiGene: Here's What You Need To Know

Benzinga 616d

Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

TipRanks 616d

Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Puma Biotechnology (PBYI) and BeiGene (BGNE)

Benzinga 624d

The Latest Analyst Ratings for BeiGene

Benzinga 624d

Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023

Benzinga 625d

Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga 625d

Tesla, Crinetics Pharmaceuticals And Other Big Stocks Moving Higher In Monday's Pre-Market Session

TipRanks 629d

China is in Trouble. Are Chinese Stocks Investable?

Benzinga 638d

PDD Holdings, UP Fintech Holding, Big Lots And Other Big Stocks Moving Higher On Tuesday

Benzinga 638d

Verizon To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Tuesday

Benzinga 644d

Who Are Other Players Gaining From Roche's Accidental Lung Cancer Data Update

Benzinga 650d

Analyst Expectations for BeiGene's Future

Seeking Alpha 650d

Jefferies starts BeiGene at buy, cites deep pipeline, Novartis partnership

Benzinga 650d

Benzinga's Top Ratings Upgrades, Downgrades For August 17, 2023

TipRanks 653d

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Agilon Health (AGL), BeiGene (BGNE) and Trevi Therapeutics (TRVI)

TipRanks 664d

Bernstein Keeps Their Hold Rating on BeiGene (BGNE)

Seeking Alpha 665d

BeiGene beats top and bottom line Q2 estimates

Seeking Alpha 666d

Notable earnings before Wednesday's open

Markets Insider Automation 666d

BeiGene earnings preview: what Wall Street is expecting

Benzinga 673d

Growing Competition in Hematology, Aesthetics Complicates AbbVie's Post-Humira Landscape, Analyst Says

Seeking Alpha 677d

BeiGene drug gets positive EMA panel opinion for esophageal cancer

TipRanks 679d

Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV) and BeiGene (BGNE)

Benzinga 681d

BeiGene's Brukinsa Positioned as Preferred BTK Inhibitor: Analyst Says Survey Supports Bullish View

	
		OSZAR »